• Source: Ralaniten

Ralaniten (developmental code name EPI-002) is an N-terminal domain antiandrogen which was never marketed. It is a derivative of bisphenol A and one of the four stereoisomers of EPI-001. A prodrug of ralaniten, ralaniten acetate (EPI-506), was under development for the treatment of prostate cancer.




See also


EPI-7386




References

Kata Kunci Pencarian:

• Ralaniten
• Ralaniten acetate
• Masofaniten
• Thalidomide
• Testosterone
• Stanozolol
• Chlorodehydromethyltestosterone
• Androgen
• Oxandrolone
• Methasterone